Evaluation of furfuryl alcohol sensitization potential following dermal and pulmonary exposure: enhancement of airway responsiveness.

Jennifer Franko, Laurel G Jackson, Ann Hubbs, Michael Kashon, B J Meade, Stacey E Anderson
Author Information
  1. Jennifer Franko: National Institute for Occupational Safety and Health, Health Effects Laboratory Division, Morgantown, West Virginia 26505, USA.

Abstract

furfuryl alcohol is considered by the U.S. Environmental Protection Agency to be a high volume production chemical, with over 1 million pounds produced annually. Due to its high production volume and its numerous industrial and consumer uses, there is considerable potential for work-related exposure, as well as exposure to the general population, through pulmonary, oral, and dermal routes of exposure. Human exposure data report a high incidence of asthma in foundry mold workers exposed to furan resins, suggesting potential immunologic effects. Although furfuryl alcohol was nominated and evaluated for its carcinogenic potential by the National Toxicology Program, studies evaluating its immunotoxicity are lacking. The studies presented here evaluated the immunotoxic potential of furfuryl alcohol following exposure by the dermal and pulmonary routes using a murine model. When tested in a combined irritancy local lymph node assay, furfuryl alcohol was identified to be an irritant and mild sensitizer (EC3 = 25.6%). Pulmonary exposure to 2% furfuryl alcohol resulted in enhanced airway hyperreactivity, eosinophilic infiltration into the lungs, and enhanced cytokine production (IL-4, IL-5, and interferon-��) by ex vivo stimulated lung-associated draining lymphoid cells. airway hyperreactivity and eosinophilic lung infiltration were augmented by prior dermal exposure to furfuryl alcohol. These results suggest that furfuryl alcohol may play a role in the development of allergic airway disease and encourage the need for additional investigation.

References

  1. MMWR Surveill Summ. 2007 Oct 19;56(8):1-54 [PMID: 17947969]
  2. Fed Regist. 1999 Mar 23;64(55):14006-7 [PMID: 10558409]
  3. J Immunol. 2010 Nov 1;185(9):5040-7 [PMID: 20870945]
  4. J Immunoassay. 2000 May-Aug;21(2-3):165-209 [PMID: 10929886]
  5. Regul Toxicol Pharmacol. 2010 Feb;56(1):54-66 [PMID: 19733604]
  6. J Toxicol Environ Health A. 2003 Aug 8;66(15):1441-52 [PMID: 12857634]
  7. Environ Res. 1983 Aug;31(2):420-7 [PMID: 6884301]
  8. Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):67-76 [PMID: 19907312]
  9. Toxicol Sci. 1999 Apr;48(2):206-17 [PMID: 10353312]
  10. J Immunol Methods. 2007 Oct 31;327(1-2):63-74 [PMID: 17716680]
  11. J Allergy Clin Immunol. 1980 Dec;66(6):458-63 [PMID: 6159383]
  12. J Allergy Clin Immunol. 2004 Feb;113(2):320-6 [PMID: 14767449]
  13. Occup Environ Med. 2001 Oct;58(10):656-62 [PMID: 11555687]
  14. CRC Crit Rev Food Sci Nutr. 1979;11(4):355-400 [PMID: 378551]
  15. Int Arch Allergy Immunol. 2002 Jul;128(3):204-11 [PMID: 12119502]
  16. Int Arch Occup Environ Health. 1978 Sep 15;42(1):41-9 [PMID: 711349]
  17. Occup Med (Lond). 1999 Nov;49(8):499-505 [PMID: 10658302]
  18. Environ Health Perspect. 2002 Aug;110 Suppl 4:569-72 [PMID: 12194889]
  19. Curr Opin Allergy Clin Immunol. 2008 Feb;8(1):44-8 [PMID: 18188017]
  20. N Engl J Med. 2001 Feb 1;344(5):350-62 [PMID: 11172168]
  21. Scand J Work Environ Health. 1976;2 Suppl 1:50-3 [PMID: 968465]
  22. Toxicol Appl Pharmacol. 2002 Aug 15;183(1):23-40 [PMID: 12217639]
  23. Int Arch Occup Environ Health. 1991;63(3):175-80 [PMID: 1917067]
  24. Nat Immunol. 2002 Aug;3(8):715-20 [PMID: 12145657]
  25. Br J Ind Med. 1985 Feb;42(2):101-5 [PMID: 3970867]
  26. J Appl Toxicol. 1999 Jul-Aug;19(4):261-6 [PMID: 10439340]
  27. J Immunol. 2007 Aug 1;179(3):1864-71 [PMID: 17641053]
  28. J Immunotoxicol. 2009 Jun;6(2):75-83 [PMID: 19589094]
  29. Am J Ind Med. 1999 Sep;Suppl 1:139-41 [PMID: 10519814]
  30. Toxicol Pathol. 2008 Feb;36(2):330-44 [PMID: 18474946]

Grants

  1. CC999999/Intramural CDC HHS

MeSH Term

Administration, Topical
Air Pollutants
Animals
Bronchoalveolar Lavage Fluid
Cells, Cultured
Dermatitis, Allergic Contact
Dermatitis, Irritant
Female
Furans
Immunoglobulin E
Inhalation Exposure
Interferon-gamma
Interleukin-4
Interleukin-5
Local Lymph Node Assay
Lung
Lymph Nodes
Mice
Mice, Inbred BALB C
Respiratory Hypersensitivity

Chemicals

Air Pollutants
Furans
Interleukin-5
Interleukin-4
Immunoglobulin E
Interferon-gamma
furfuryl alcohol

Word Cloud

Created with Highcharts 10.0.0alcoholexposurefurfurylpotentialdermalhighproductionpulmonaryairwayvolumeroutesevaluatedstudiesfollowingenhancedhyperreactivityeosinophilicinfiltrationFurfurylconsideredUSEnvironmentalProtectionAgencychemical1millionpoundsproducedannuallyDuenumerousindustrialconsumerusesconsiderablework-relatedwellgeneralpopulationoralHumandatareportincidenceasthmafoundrymoldworkersexposedfuranresinssuggestingimmunologiceffectsAlthoughnominatedcarcinogenicNationalToxicologyProgramevaluatingimmunotoxicitylackingpresentedimmunotoxicusingmurinemodeltestedcombinedirritancylocallymphnodeassayidentifiedirritantmildsensitizerEC3=256%Pulmonary2%resultedlungscytokineIL-4IL-5interferon-��exvivostimulatedlung-associateddraininglymphoidcellsAirwaylungaugmentedpriorresultssuggestmayplayroledevelopmentallergicdiseaseencourageneedadditionalinvestigationEvaluationsensitizationexposure:enhancementresponsiveness

Similar Articles

Cited By (5)